A

Asklepios BioPharmaceutical, Inc. (AskBio)

372 employees

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Gene Therapy
AAV Manufacturing
Nucleic Acid
Doggybone DNA
Health Care
AAV
Medical
Molecular Medicine
Manufacturing
Biopharma
Epigenome
Adeno-Associated Virus
Rare Disease

Date founded

2001

Funding rounds raised

Total raised

$235M

from 2 investors over 2 rounds

A

Asklepios BioPharmaceutical, Inc. (AskBio) raised $2.7M on September 2, 2020

Investors: Scottish Enterprise

A

Asklepios BioPharmaceutical, Inc. (AskBio) raised $235M on April 11, 2019

Investors: Vida Ventures, LLC

FAQ